- Anniversary
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Intrahepatic cholestasis of pregnancy is associated with significant risk of stillbirth which contributes to variation in clinical management. Recent Society for Maternal-Fetal Medicine guidance recommends 36 week delivery for patients with serum bile acids >100 umol/L, consideration for delivery between 36-39 weeks stratified by bile acid level, and against preterm delivery for those with clinical features of cholestasis without bile acid elevation.